Sponsored by:

Nuclear Medicine: Page 124

PET/MRI makes clinical inroads, but work remains
By Michael Reiter
PET/MRI is making progress in moving from being a research technology to a modality that's used clinically. Radiologists who use it frequently are recognizing its value for several applications, but work remains in convincing referring physicians of its worth.
August 30, 2015
Lantheus appoints Heino as president and CEO
By AuntMinnie.com staff writers
Lantheus Medical Imaging's parent company, Lantheus Holdings, said it has appointed Mary Anne Heino as president and CEO.
August 27, 2015
International Isotopes' Q2 revenues drop
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes experienced lower revenues in its second quarter of 2015, although the firm's net loss narrowed.
August 17, 2015
Online tool calculates cost of stress tests
By AuntMinnie.com staff writers
University Nuclear and Diagnostics has unveiled a new Web-based calculator that determines the precise cost of nuclear stress tests.
August 16, 2015
CCTA, SPECT MPI yield similar outcomes in chest pain
By Eric Barnes
Although they provide different radiation exposure levels and patient experiences, SPECT myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA) produce remarkably similar outcomes in initial imaging for chest pain, according to a new study.
August 12, 2015
Lantheus posts revenue drop, loss in Q2
By AuntMinnie.com staff writers
Strong sales of Lantheus Medical Imaging's Definity echocardiography contrast agent were counterbalanced by a drop in nuclear medicine revenue for the second quarter of 2015.
August 4, 2015
IBA divests North American subsidiary
By AuntMinnie.com staff writers
Proton therapy developer Ion Beam Applications (IBA) has completed the divestiture of IBA Molecular North America to Illinois Health and Science.
August 2, 2015
Navidea's Q2 revenues grow, losses decrease
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals posted upticks in revenue and a lower net loss in its second quarter of 2015.
July 29, 2015
PET/CT tumor volume best predicts breast cancer survival
By Wayne Forrest
Whole-body metabolic tumor volume, as determined by FDG-PET/CT before treatment, is a reliable prognosticator of overall survival in patients who have invasive ductal carcinoma of the breast and distant metastases at the time of their initial diagnosis, according to a study published online July 23 in the American Journal of Roentgenology.
July 29, 2015
Navidea wins NIH grant
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has received a $321,000 grant from the U.S. National Institutes of Health's (NIH) National Heart, Lung, and Blood Institute.
July 27, 2015
Guerbet bids to buy Mallinckrodt's contrast business
By Brian Casey
French contrast agent developer Guerbet plans to acquire the contrast media and injector business of U.S. firm Mallinckrodt. The $270 million deal will double Guerbet's annual revenues, expand its product line, and instantly make the company a major player in the U.S. contrast market.
July 26, 2015
Perma-Fix subsidiary partners with Digirad for Tc-99m deal
By AuntMinnie.com staff writers
Perma-Fix Environmental Services announced that its Polish subsidiary, Perma-Fix Medical, has finalized its partnership with nuclear medicine firm Digirad regarding technetium-99m (Tc-99m).
July 26, 2015
Previous Page
Page 124 of 438
Next Page